Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells

Tangeretin boosts the anticancer activity of metformin in breast cancer cells via curbing the energy production

(2021) Bushra Mdkhana et al.   PHYTOMEDICINE

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer

(2020) K.G.K. Deepak et al.   PHARMACOLOGICAL RESEARCH

The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers

(2019) Mai F. Tolba et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Breast cancer statistics, 2019

(2019) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts

(2018) Carrie D. House et al.   BMC CANCER

PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside

(2018) Anita A. Turk et al.   CANCER

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling

(2018) Chaido Sirinian et al.   ONCOGENE

The nuclear factor-kappa B pathway and response to treatment in breast cancer

(2017) Yeon Hee Park   PHARMACOGENOMICS

NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer

(2017) Behrad Darvishi et al.   TUMOR BIOLOGY

The relationship between members of the canonical NF-κB pathway, components of tumour microenvironment and survival in patients with invasive ductal breast cancer

(2017) Lindsay Bennett et al.   Oncotarget

Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells

(2017) Francesco Ciccarese et al.   Frontiers in Oncology

Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)

(2016) D. Mavroudis et al.   ANNALS OF ONCOLOGY

Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma

(2016) Xing Bao et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial

(2016) Laura Pizzuti et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis

(2015) Bodu Liu et al.   CANCER CELL

Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving Pathways

(2015) Kubra Karagoz et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Preferential cytotoxicity of bortezomib toward highly malignant human liposarcoma cells via suppression of MDR1 expression and function

(2015) Yamei Hu et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance

(2015) Shang-Hsun Tsou et al.   PLoS One

Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth

(2014) Thanh U. Barbie et al.   JOURNAL OF CLINICAL INVESTIGATION

Efficient induction of apoptosis by proteasome inhibitor: bortezomib in the human breast cancer cell line MDA-MB-231

(2014) Rafał Krętowski et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells

(2013) Fabio Petrocca et al.   CANCER CELL

The interaction of bortezomib with multidrug transporters: implications for therapeutic applications in advanced multiple myeloma and other neoplasias

(2013) Robert O’Connor et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Curbing the focal adhesion kinase and its associated signaling events by pentoxifylline in MDA-MB-231 human breast cancer cells

(2013) Peeyush N. Goel et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Paracrine control of tissue regeneration and cell proliferation by Caspase-3

(2013) K Boland et al.   Cell Death & Disease

Potentiation of Anticancer Drugs: Effects of Pentoxifylline on Neoplastic Cells

(2011) Miroslav Barancik et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells

(2011) Peeyush N. Goel et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B

(2009) Bor-Sheng Ko et al.   LIFE SCIENCES